ESMO 2014

Oncology Meeting Resources

26 Sep - 30 Sep 2014, Madrid, Spain

ESMO 2014 Congress

The theme for ESMO 2014 was ‘Precision Medicine in Cancer Care.’ Whether you are a medical or surgical oncologist or a radiation oncologist, immunologist or pathologist, practising precision medicine means we are all working towards a common goal – improved patient outcomes. For your convenience and due to the large quantity of information coming from the ESMO 2014 congress, we have split the presentations up by main congress topic to allow you to find the information you need more easily.

Search through all presentations

Here, you will find the abstracts, posters, PDF presentation and webcasts from ESMO 2014 to the extent the presenters have consented to release their contribution or a slightly modified version thereof. Please, note that the publication of these presentations is a courtesy of the originating authors and is for personal educational purposes only.

Special Sessions and Tracks

Useful links





Format available

http://oncologypro.esmo.org/Meeting-Resourc...erapy-vs-targeted-therapy-in-first-line-BRAF

Date: 27 Sep 2014
Presenter: James Larkin
Resources: Presentation, Webcast
Topics: Anti-Cancer Agents & Biologic Therapy, Cancer Immunology and Immunotherapy, Melanoma and other Skin Tumours

http://oncologypro.esmo.org/Meeting-Resourc...Invited-discussant-abstracts-1048O-and-1049O

Date: 27 Sep 2014
Presenter: George Coukos
Resources: Presentation
Topics: Cancer Immunology and Immunotherapy, Translational Research

http://oncologypro.esmo.org/Meeting-Resources/ESMO-2014/Invited-discussant-abstract-1050O

Date: 27 Sep 2014
Presenter: Martin Gore
Resources: Presentation
Topic: Cancer Immunology and Immunotherapy

http://oncologypro.esmo.org/Meeting-Resourc...e-dose-interleukin-2-for-metastatic-melanoma

AimAdoptive cell therapy (ACT) with tumor infiltrating lymphocytes (TILs) achieved impressive clinical results in several single institution phase I/II clinical trials performed outside Europe, and...

Date: 27 Sep 2014
Presenter: Rikke Andersen
Resources: Abstract, Presentation, Webcast
Topics: Cancer Immunology and Immunotherapy, Melanoma and other Skin Tumours, Translational Research

http://oncologypro.esmo.org/Meeting-Resourc...-locally-advanced-or-metastatic-solid-tumors

AimPD-L1 mediates cancer immune evasion, and blocking PD-L1 represents a cancer immunotherapy strategy that can restore tumor-specific T-cell immunity. MPDL3280A, a human monoclonal antibody containing...

Date: 27 Sep 2014
Presenter: Christopher Lieu
Resources: Abstract, Presentation, Webcast
Topic: Cancer Immunology and Immunotherapy

http://oncologypro.esmo.org/Meeting-Resourc...umab-in-metastatic-renal-cell-carcinoma-mRCC

AimNivolumab, a fully human IgG4 PD-1 immune checkpoint inhibitor antibody, has shown durable responses and encouraging overall survival (OS) data in mRCC. IPI, a fully human monoclonal antibody to...

Date: 27 Sep 2014
Presenter: Hans Hammers
Resources: Abstract, Presentation, Webcast
Topics: Anti-Cancer Agents & Biologic Therapy, Renal Cell Cancer, Cancer Immunology and Immunotherapy

http://oncologypro.esmo.org/Meeting-Resourc...ernal-quality-assessement-in-immuno-oncology

Body Abstract:The important role of immunohistochemistry (IHC) is well known. IHC will recognize antigens and, consequently, identify and classify specific cells within a cell population whose morphology...

Date: 27 Sep 2014
Presenter: Els Dequeker
Resources: Abstract
Topics: Cancer Immunology and Immunotherapy, Pathology/Molecular Biology

http://oncologypro.esmo.org/Meeting-Resourc...14/How-to-quantify-immuohistochemical-slides

Body Abstract:The quantitative interpretation of immunohistochemistry (IHC) is typically performed by a subjective evaluation based either on binary positive-negative or semi-quantitative assessments...

Date: 27 Sep 2014
Presenter: Anna Sapino
Resources: Abstract
Topics: Cancer Immunology and Immunotherapy, Pathology/Molecular Biology

http://oncologypro.esmo.org/Meeting-Resourc...preanalytical-phase-for-immunohistochemistry

Body Abstract:The importance of the preanalytical phase for immunohistochemistry Preanalytical treatment of tissues was studiedto clarify pitfalls in immunohistochemistry (IHC) and, in general, in...

Date: 27 Sep 2014
Presenter: Giorgio Stanta
Resources: Abstract
Topics: Cancer Immunology and Immunotherapy, Pathology/Molecular Biology

http://oncologypro.esmo.org/Meeting-Resourc...at-the-oncologist-needs-from-the-pathologist

BodyNo abstract received at time of going to press

Date: 27 Sep 2014
Presenter: Fortunato Ciardiello
Resources: Abstract
Topics: Cancer Immunology and Immunotherapy, Pathology/Molecular Biology